| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 91917-63-4 | 人α-ANF(I-28) | Atrial natriureticpeptide-28 (human reduced) (9CI); Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-; 13: PN: WO2004089280 SEQID: 13 unclaimed sequence; 13: PN: WO2005103087 SEQID:16 unclaimed sequence; 140: PN: WO2008058016 SEQID: 141 claimed protein; 15:PN: US20030119021 SEQID: 14 unclaimed sequence; 15: PN: WO2008154226 SEQID: 15unclaimed protein; 16: PN: WO0071576 SEQID: 16 unclaimed sequence; 18: PN:WO2004022003 SEQID: 4 claimed sequence; 18: PN: WO2005094420 SEQID: 4 claimedsequence; 19: PN: WO2007034498 SEQID: 18 unclaimed sequence; 1: PN: DE19942230SEQID: 6 claimed protein; 1: PN: US20030069186 SEQID: 5 unclaimed sequence; 1:PN: US20090163421 SEQID: 1 unclaimed sequence; 1: PN: WO0185945 SEQID: 1unclaimed sequence; 2145: PN: WO03060071 SEQID: 2207 unclaimed; 21: PN:WO2004045592 SEQID: 20 unclaimed sequence; 220: PN: US20060293232 PAGE: 14unclaimed sequence; 294: PN: WO0069900 SEQID: 476 unclaimed sequence; 2: PN:GB2403533 SEQID: 2 claimed sequence; 2: PN: WO02074234 FIGURE: 3B claimedprotein; 301: PN: US20080004206 SEQID: 302 unclaimed protein; 313: PN:WO0069900 SEQID: 495 unclaimed sequence; 38: PN: WO2005003296 SEQID: 309unclaimed sequence; 393: PN: US20090175821 SEQID: 476 claimed protein; 3: PN:CN1278007 SEQID: 5 unclaimed sequence; 3: PN: US20080194481 SEQID: 302 claimedprotein; 439: PN: US20080312157 SEQID: 456 unclaimed sequence; 4: PN:US20080214437 SEQID: 4 claimed protein; 4: PN: WO2009073527 SEQID: 4 claimedprotein; 4: PN: WO2009142307 SEQID: 100 claimed protein; 5-32-Urodilatin(human); 59: PN: US6033884 SEQID: 53 unclaimed protein; 5: PN: WO2007035600SEQID: 3 unclaimed sequence; 604: PN: WO2009058322 SEQID: 302 claimed sequence; 78: PN: WO03099862 PAGE: 45 unclaimed protein; 7: PN: US20060183154 SEQID: 7claimed sequence; 95: PN: WO2007047504 SEQID: 179 unclaimed sequence; 99-126-natriuretic hormone peptide (human); 9: PN: US20010027181 SEQID: 1unclaimed protein; Atriopeptin-28 (Canis familiaris reduced); |  | C127H205N45O39S3 | 詳情 | 供應商 |
| 130093-13-9 | Adipokinetic hormoneprecursor-related peptide 1 (Schistocerca gregaria reduced) (9CI); Adipokinetichormone precursor-related peptide 2 (Schistocerca gregaria a-chain reduced); L-Asparagine, L-a-aspartyl-L-alanyl-L-alanyl-L-a-aspartyl-L-phenylalanylglycyl-L-a-aspartyl-L-prolyl-L-tyrosyl-L-seryl-L-phenylalanyl-L-leucyl-L-tyrosyl-L-arginyl-L-leucyl-L-isoleucyl-L-glutaminyl-L-alanyl-L-a-glutamyl-L-alanyl-L-arginyl-L-lysyl-L-methionyl-L-serylglycyl-L-cysteinyl-L-seryl-; Protein (Schistocerca gregaria prepro-adipokinetic hormone I C-terminal a-chain) |  | C136H205N37O44S2 | 詳情 | 供應商 | |
| 105091-13-2 | Prothoracotropin II(silkworm B-28-chain reduced) (9CI); Bombyxin II(B-chain reduced); L-Aspartic acid,5-oxo-L-prolyl-L-glutaminyl-L-prolyl-L-glutaminyl-L-alanyl-L-valyl-L-histidyl-L-threonyl-L-tyrosyl-L-cysteinylglycyl-L-arginyl-L-histidyl-L-leucyl-L-alanyl-L-arginyl-L-threonyl-L-leucyl-L-alanyl-L-a-aspartyl-L-leucyl-L-cysteinyl-L-tryptophyl-L-a-glutamyl-L-alanylglycyl-L-valyl- |  | C135H205N41O41S2 | 詳情 | 供應商 | |
| 161902-50-7 | 8-32-Calcitonin (salmonreduced), N-acetyl-30-L-asparagine-32-L-tyrosinamide-; Calcitonin(salmon reduced),1-de-L-cysteine-2-de-L-serine-3-de-L-asparagine-4-de-L-leucine-5-de-L-serine-6-de-L-threonine-7-de-L-cysteine-8-(N-acetyl-L-valine)-30-L-asparagine-32-L-tyrosinamide-; AC 187 |  | C127H205N37O40 | 詳情 | 供應商 | |
| 151804-77-2 | 8-32-Calcitonin (salmonreduced), N-acetyl-30-L-asparagine-32-L-tyrosinamide-; Calcitonin(salmon reduced),1-de-L-cysteine-2-de-L-serine-3-de-L-asparagine-4-de-L-leucine-5-de-L-serine-6-de-L-threonine-7-de-L-cysteine-8-(N-acetyl-L-valine)-30-L-asparagine-32-L-tyrosinamide-; AC 187 |  | C127H205N37O40 | 詳情 | 供應商 | |
| 88898-17-3 | ANF (1-28), RAT | ATRIAL NATRIURETIC FACTOR (1-28) (RAT); ANF (123-150), RAT; ANF (1-28), RAT; ANF 1-28; ANP (RAT, 1-28) (RABBIT, MOUSE); ANP 1-28, RAT; ANP (123-150), RAT; ALPHA-ATRIOPEPTIN, RAT; ALPHA-ANF 1-28, RAT |  | C128H205N45O39S2 | 詳情 | 供應商 |
| 148067-21-4 | ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO | ITSFEEAKGLDRINERMPPRRDAMP; CN412; ITSFEEAKGLDRINERMPPRRDAMP; H-ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO-OH; ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO; CALCINEURIN AUTOINHIBITORY FRAGMENT; CALCINEURIN AUTOINHIBITORY PEPTIDE; H-Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro-OH |  | C124H205N39O39S2 | 詳情 | 供應商 |
| 330936-69-1 | MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA | HUMANIN TRIFLUOROACETATE; MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA; MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA TRIFLUOROACETATE; MAPRGFSCLLLLTSEIDLPVKRRA; HN; HNMET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA; H-MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA-OH; H-MAPRGFSCLLLLTSEIDLPVKRRA-OH; HUMANIN (HUMAN) |  | C121H205F3N34O34S2 | 詳情 | 供應商 |